After pretreatment with the FTO inhibitors CS1 or CS2, AML cells with high expression of LILRB4 were subsequently co-cultured with activated T cells, displaying that LILRB4 expression was significantly decreased and that the killing effect of T cells on AML cells was remarkably enhanced (101). This evidence concerns the gene FTO and acute myeloid leukemia.